- Home
- DTIL vs LCNB Comparison
DTIL vs LCNB Comparison
Compare DTIL & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | LCNB |
|---|---|---|
| Founded | 2006 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.7M | 223.1M |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | DTIL | LCNB |
|---|---|---|
| Price | $7.29 | $20.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 632.2K | 44.1K |
| Earning Date | 05-14-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.43% |
| EPS Growth | N/A | ★ 68.04 |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ $1,070,000,000.00 | $6,445,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $3.66 |
| P/E Ratio | ★ N/A | $63.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $14.11 |
| 52 Week High | $9.62 | $20.62 |
Technical Indicators
Market Signals| Indicator | DTIL | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 67.99 |
| Support Level | $6.30 | $15.53 |
| Resistance Level | $7.96 | N/A |
| Average True Range (ATR) | 0.62 | 0.80 |
| MACD | -0.19 | 0.16 |
| Stochastic Oscillator | 11.37 | 84.60 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.